申请人:——
公开号:US20040044059A1
公开(公告)日:2004-03-04
A diverse set of tubulin binding agents have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for molecular recognition of tubulin. In phenolic or amino form, these ligands may be further functionalized to prepare phosphate esters, phosphate salts, phosphoramidates, and other prodrugs capable of demonstrating selective targeting and destruction of tumor cell vasculature.
已发现了一系列多样化的针对微管蛋白结合的药物,这些药物在结构上一般特征是具有半刚性分子框架,能够保持适合于识别微管蛋白的芳基-芳基、伪π-π堆积距离。在酚基或氨基形式中,这些配体可以进一步功能化,制备磷酸酯、磷酸盐、磷酰胺酯和其他前药,能够表现出对肿瘤细胞血管的选择性靶向和破坏。